Polyunsaturated Fatty Acids in Perinatal Depression: A Systematic Review and Meta-analysis

Biological Psychiatry

Volumn 82, Issue 8, 2017, Pages 560-569

  Lin, Pao Yen ^b,c   Chang, Cheng Ho ^a   Chong, Mary Foong Fong ^d,e   Chen, Helen ^f,g   Su, Kuan Pin ^h,i  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d AGENCY FOR SCIENCE   (Singapore)

^e NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^f KK Women's and Children's Hospital   (United Kingdom)

^g DUKE NUS MEDICAL SCHOOL   (Singapore)

^h CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

ⁱ CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Arachidonic acid; Docosahexaenoic acid; Eicosapentaenoic acid; Omega 3; Perinatal depression; Polyunsaturated fatty acids

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; ANTIDEPRESSANT AGENT; UNSATURATED FATTY ACID;

ANTENATAL DEPRESSION; ARTICLE; DISEASE ASSOCIATION; EDINBURGH POSTNATAL DEPRESSION SCALE; HUMAN; LIPID COMPOSITION; MAJOR DEPRESSION; NONHUMAN; POSTNATAL DEPRESSION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; FEMALE; META ANALYSIS;

ANTIDEPRESSIVE AGENTS; DEPRESSION, POSTPARTUM; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS;

EID: 85017331964     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2017.02.1182     Document Type: Article

References (73)

1. Gavin, N.I., Gaynes, B.N., Lohr, K.N., Meltzer-Brody, S., Gartlehner, G., Swinson, T., Perinatal depression: A systematic review of prevalence and incidence. Obstet Gynecol 106 (2005), 1071–1083.
2. Bennett, H.A., Einarson, A., Taddio, A., Koren, G., Einarson, T.R., Prevalence of depression during pregnancy: Systematic review. Obstet Gynecol 103 (2004), 698–709.
3. Murray, L., Stein, A., The effects of postnatal depression on the infant. Baillieres Clin Obstet Gynaecol 3 (1989), 921–933.
4. Bonari, L., Pinto, N., Ahn, E., Einarson, A., Steiner, M., Koren, G., Perinatal risks of untreated depression during pregnancy. Can J Psychiatry 49 (2004), 726–735.
5. Oates, M., Suicide: The leading cause of maternal death. Br J Psychiatry 183 (2003), 279–281.
6. Burke, L., The impact of maternal depression on familial relationships. Int Rev Psychiatry 15 (2003), 243–255.
7. Orr, S.T., James, S.A., Blackmore Prince, C., Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland. Am J Epidemiol 156 (2002), 797–802.
8. Serati, M., Redaelli, M., Buoli, M., Altamura, A.C., Perinatal major depression biomarkers: A systematic review. J Affect Disord 193 (2016), 391–404.
9. Sparling, T.M., Henschke, N., Nesbitt, R.C., Gabrysch, S., The role of diet and nutritional supplementation in perinatal depression: A systematic review. Matern Child Nutr, 13, 2017.
10. Sarris, J., Logan, A.C., Akbaraly, T.N., Paul Amminger, G., Balanza-Martinez, V., Freeman, M.P., et al. International Society for Nutritional Psychiatry Research consensus position statement: Nutritional medicine in modern psychiatry. World Psychiatry 14 (2015), 370–371.
11. Demmelmair, H., Koletzko, B., Importance of fatty acids in the perinatal period. World Rev Nutr Diet 112 (2015), 31–47.
12. Su, K.P., Huang, S.Y., Chiu, T.H., Huang, K.C., Huang, C.L., Chang, H.C., et al. Omega-3 fatty acids for major depressive disorder during pregnancy: Results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 69 (2008), 644–651.
13. Blanchard, D.S., Omega-3 fatty acid supplementation in perinatal settings. MCN Am J Matern Child Nurs 31 (2006), 250–256.
14. Al, M.D., van Houwelingen, A.C., Hornstra, G., Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome. Am J Clin Nutr 71:1 suppl (2000), 285S–291S.
15. Brooks, S.L., Mitchell, A., Steffenson, N., Mothers, infants, and DHA. Implications for nursing practice. MCN Am J Matern Child Nurs 25 (2000), 71–75.
16. Su, K.P., Wang, S.M., Pae, C.U., Omega-3 polyunsaturated fatty acids for major depressive disorder. Expert Opin Investig Drugs 22 (2013), 1519–1534.
17. Su, K.P., Shen, W.W., Huang, S.Y., Effects of polyunsaturated fatty acids on psychiatric disorders. Am J Clin Nutr, 72, 2000, 1241.
18. Horrobin, D.F., Bennett, C.N., Depression and bipolar disorder: Relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot Essent Fatty Acids 60 (1999), 217–234.
19. Hibbeln, J.R., Fish consumption and major depression. Lancet, 351, 1998, 1213.
20. Lin, P.Y., Huang, S.Y., Su, K.P., A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry 68 (2010), 140–147.
21. Lin, P.Y., Mischoulon, D., Freeman, M.P., Matsuoka, Y., Hibbeln, J., Belmaker, R.H., et al. Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression. Mol Psychiatry 17 (2012), 1161–1163.
22. Lin, P.Y., Su, K.P., A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 68 (2007), 1056–1061.
23. Grosso, G., Galvano, F., Marventano, S., Malaguarnera, M., Bucolo, C., Drago, F., et al. Omega-3 fatty acids and depression: Scientific evidence and biological mechanisms. Oxid Med Cell Longev, 2014, 2014, 313570.
24. Sublette, M.E., Ellis, S.P., Geant, A.L., Mann, J.J., Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry, 72, 2011, 1577–1584.
25. Martins, J.G., EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: Evidence from a meta-analysis of randomized controlled trials. J Am Coll Nutr 28 (2009), 525–542.
26. Appleton, K.M., Hayward, R.C., Gunnell, D., Peters, T.J., Rogers, P.J., Kessler, D., et al. Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: Systematic review of published trials. Am J Clin Nutr 84 (2006), 1308–1316.
27. Bloch, M.H., Hannestad, J., Omega-3 fatty acids for the treatment of depression: Systematic review and meta-analysis. Mol Psychiatry 17 (2012), 1272–1282.
28. De Vriese, S.R., Christophe, A.B., Maes, M., Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: Further evidence that lowered n-PUFAs are related to major depression. Life Sci 73 (2003), 3181–3187.
29. Golding, J., Steer, C., Emmett, P., Davis, J.M., Hibbeln, J.R., High levels of depressive symptoms in pregnancy with low omega-3 fatty acid intake from fish. Epidemiology 20 (2009), 598–603.
30. Markhus, M.W., Skotheim, S., Graff, I.E., Froyland, L., Braarud, H.C., Stormark, K.M., et al. Low omega-3 index in pregnancy is a possible biological risk factor for postpartum depression. PLoS One, 8, 2013, e67617.
31. Hibbeln, J.R., Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: A cross-national, ecological analysis. J Affect Disord 69 (2002), 15–29.
32. Rees, A.M., Austin, M.P., Parker, G.B., Omega-3 fatty acids as a treatment for perinatal depression: Randomized double-blind placebo-controlled trial. Aust N Z J Psychiatry 42 (2008), 199–205.
33. Makrides, M., Gibson, R.A., McPhee, A.J., Yelland, L., Quinlivan, J., Ryan, P., et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: A randomized controlled trial. JAMA 304 (2010), 1675–1683.
34. Nishi, D., Su, K.P., Usuda, K., Chiang, Y.J., Guu, T.W., Hamazaki, K., et al. Omega-3 fatty acid supplementation for expectant mothers with depressive symptoms in Japan and Taiwan: An open-label trial. Psychiatry Clin Neurosci 70 (2016), 253–254.
35. Otto, S.J., de Groot, R.H.M., Hornstra, G., Increased risk of postpartum depressive symptoms is associated with slower normalization after pregnancy of the functional docosahexaenoic acid status. Prostaglandins Leukot Essent Fatty Acids 69 (2003), 237–243.
36. Browne, J.C., Scott, K.M., Silvers, K.M., Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression. J Affect Disord 90 (2006), 131–139.
37. Rees, A.M., Austin, M.P., Owen, C., Parker, G., Omega-3 deficiency associated with perinatal depression: Case control study. Psychiatry Res 166 (2009), 254–259.
38. Hamazaki, K., Harauma, A., Otaka, Y., Moriguchi, T., Inadera, H., Serum n-3 polyunsaturated fatty acids and psychological distress in early pregnancy: Adjunct Study of Japan Environment and Children's Study. Transl Psychiatry, 6, 2016, e737.
39. Shiraishi, M., Matsuzaki, M., Yatsuki, Y., Murayama, R., Severinsson, E., Haruna, M., Associations of dietary intake and plasma concentrations of eicosapentaenoic and docosahexaenoic acid with prenatal depressive symptoms in Japan. Nurs Health Sci 17 (2015), 257–262.
40. Pinto, T.J., Vilela, A.A., Farias, D.R., Lepsch, J., Cunha, G.M., Vaz, J.S., et al. Serum n-3 polyunsaturated fatty acids are inversely associated with longitudinal changes in depressive symptoms during pregnancy. Epidemiol Psychiatr Sci 26 (2017), 157–168.
41. Sallis, H., Steer, C., Paternoster, L., Davey Smith, G., Evans, J., Perinatal depression and omega-3 fatty acids: A Mendelian randomisation study. J Affect Disord 166 (2014), 124–131.
42. Chong, M.F., Ong, Y.L., Calder, P.C., Colega, M., Wong, J.X., Tan, C.S., et al. Long-chain polyunsaturated fatty acid status during pregnancy and maternal mental health in pregnancy and the postpartum period: Results from the GUSTO study. J Clin Psychiatry 76 (2015), e848–e856.
43. Shadish, W.R., Haddock, C.K., Combining estimates of effect size. Cooper, H., Hedges, L.V., (eds.) The Handbook of Research Synthesis, 1994, Russell Sage Foundation, New York, 261–281.
44. Egger, M., Davey Smith, G., Schneider, M., Minder, C., Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997), 629–634.
45. Duval, S., Tweedie, R., Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics, 56, 2000, 455–463.
46. Thornton, A., Lee, P., Publication bias in meta-analysis: Its causes and consequences. J Clin Epidemiol 53 (2000), 207–216.
47. Herzog, R., Alvarez-Pasquin, M.J., Diaz, C., Del Barrio, J.L., Estrada, J.M., Gil, A., Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health, 13, 2013, 154.
48. Stroup, D.F., Berlin, J.A., Morton, S.C., Olkin, I., Williamson, G.D., Rennie, D., et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000), 2008–2012.
49. Parker, G., Hegarty, B., Granville-Smith, I., Ho, J., Paterson, A., Gokiert, A., et al. Is essential fatty acid status in late pregnancy predictive of post-natal depression?. Acta Psychiatr Scand 131 (2015), 148–156.
50. Su, K.P., Matsuoka, Y., Pae, C.U., Omega-3 polyunsaturated fatty acids in prevention of mood and anxiety disorders. Clin Psychopharmacol Neurosci 13 (2015), 129–137.
51. Su, K.P., Biological mechanism of antidepressant effect of omega-3 fatty acids: How does fish oil act as a ‘mind-body interface’?. Neurosignals 17 (2009), 144–152.
52. Delion, S., Chalon, S., Herault, J., Guilloteau, D., Besnard, J.C., Durand, G., Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotoninergic neurotransmission in rats. J Nutr 124 (1994), 2466–2476.
53. Chalon, S., Vancassel, S., Zimmer, L., Guilloteau, D., Durand, G., Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission. Lipids 36 (2001), 937–944.
54. Berg, K.A., Maayani, S., Clarke, W.P., 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism. Mol Pharmacol 50 (1996), 1017–1023.
55. Su, K.P., Inflammation in psychopathology of depression: Clinical, biological, and therapeutic implications. Biomedicine (Taipei) 2 (2012), 68–74.
56. Blondeau, N., Nguemeni, C., Debruyne, D.N., Piens, M., Wu, X., Pan, H., et al. Subchronic alpha-linolenic acid treatment enhances brain plasticity and exerts an antidepressant effect: A versatile potential therapy for stroke. Neuropsychopharmacology 34 (2009), 2548–2559.
57. Venna, V.R., Deplanque, D., Allet, C., Belarbi, K., Hamdane, M., Bordet, R., PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 34 (2009), 199–211.
58. Rao, J.S., Ertley, R.N., Lee, H.J., DeMar, J.C. Jr, Arnold, J.T., Rapoport, S.I., et al. n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry 12 (2007), 36–46.
59. Wu, A., Ying, Z., Gomez-Pinilla, F., Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 21 (2004), 1457–1467.
60. da Rocha, C.M., Kac, G., High dietary ratio of omega-6 to omega-3 polyunsaturated acids during pregnancy and prevalence of post-partum depression. Matern Child Nutr 8 (2012), 36–48.
61. Simopoulos, A.P., Evolutionary aspects of diet: The omega-6/omega-3 ratio and the brain. Mol Neurobiol 44 (2011), 203–215.
62. Simopoulos, A.P., An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients, 8, 2016, 128.
63. Raison, C.L., Capuron, L., Miller, A.H., Cytokines sing the blues: Inflammation and the pathogenesis of depression. Trends Immunol 27 (2006), 24–31.
64. Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci 9 (2008), 46–56.
65. Martinez, M., Ballabriga, A., Gil-Gibernau, J.J., Lipids of the developing human retina: I. Total fatty acids, plasmalogens, and fatty acid composition of ethanolamine and choline phosphoglycerides. J Neurosci Res 20 (1988), 484–490.
66. Makrides, M., Neumann, M.A., Byard, R.W., Simmer, K., Gibson, R.A., Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 60 (1994), 189–194.
67. Neuringer, M., Connor, W.E., Lin, D.S., Barstad, L., Luck, S., Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys. Proc Natl Acad Sci U S A 83 (1986), 4021–4025.
68. Markhus, M.W., Rasinger, J.D., Malde, M.K., Froyland, L., Skotheim, S., Braarud, H.C., et al. Docosahexaenoic acid status in pregnancy determines the maternal docosahexaenoic acid status 3-, 6- and 12 months postpartum. Results from a longitudinal observational study. PLoS One, 10, 2015, e0136409.
69. Min, Y., Ghebremeskel, K., Crawford, M.A., Nam, J.H., Kim, A., Koo, J.N., et al. Pregnancy reduces arachidonic and docosahexaenoic in plasma triacylglycerols of Korean women. Int J Vitam Nutr Res 70 (2000), 70–75.
70. Gellert, S., Schuchardt, J.P., Hahn, A., Higher omega-3 index and DHA status in pregnant women compared to lactating women - Results from a German nation-wide cross-sectional study. Prostaglandins Leukot Essent Fatty Acids 109 (2016), 22–28.
71. Assies, J., Pouwer, F., Lok, A., Mocking, R.J., Bockting, C.L., Visser, I., et al. Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: A matched case-control study. PLoS One, 5, 2010, e10635.
72. Bradbury, K.E., Skeaff, C.M., Green, T.J., Gray, A.R., Crowe, F.L., The serum fatty acids myristic acid and linoleic acid are better predictors of serum cholesterol concentrations when measured as molecular percentages rather than as absolute concentrations. Am J Clin Nutr 91 (2010), 398–405.
73. Sarris, J., Logan, A.C., Akbaraly, T.N., Amminger, G.P., Balanza-Martinez, V., Freeman, M.P., et al. Nutritional medicine as mainstream in psychiatry. Lancet Psychiatry 2 (2015), 271–274.